|
HY-100131-10mg
|
MedChemexpress LLC
|
GSK481 [CAS 1622849-58-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-100131-100mg
|
MedChemexpress LLC
|
GSK481 [CAS 1622849-58-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-100131-2mg
|
MedChemexpress LLC
|
GSK481 [CAS 1622849-58-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-100131-5mg
|
MedChemexpress LLC
|
GSK481 [CAS 1622849-58-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-100131-50mg
|
MedChemexpress LLC
|
GSK481 [CAS 1622849-58-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-10037-10mg
|
MedChemexpress LLC
|
Quiflapon [CAS 136668-42-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-10037-100mg
|
MedChemexpress LLC
|
Quiflapon [CAS 136668-42-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-10037-5mg
|
MedChemexpress LLC
|
Quiflapon [CAS 136668-42-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-10037-50mg
|
MedChemexpress LLC
|
Quiflapon [CAS 136668-42-3]
|
|
COVID-19-immunoregulation
|
|
|
HY-103428-10mg
|
MedChemexpress LLC
|
LE 300 [CAS 274694-98-3]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-109066-10mg
|
MedChemexpress LLC
|
Olinciguat [CAS 1628732-62-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-109066-100mg
|
MedChemexpress LLC
|
Olinciguat [CAS 1628732-62-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-109066-5mg
|
MedChemexpress LLC
|
Olinciguat [CAS 1628732-62-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-109066-50mg
|
MedChemexpress LLC
|
Olinciguat [CAS 1628732-62-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-111551-10mg
|
MedChemexpress LLC
|
FT113 [CAS 1630808-89-7]
|
|
Cancer-programmed cell death
|
|
|
HY-111551-100mg
|
MedChemexpress LLC
|
FT113 [CAS 1630808-89-7]
|
|
Cancer-programmed cell death
|
|
|
HY-111551-5mg
|
MedChemexpress LLC
|
FT113 [CAS 1630808-89-7]
|
|
Cancer-programmed cell death
|
|
|
HY-111551-50mg
|
MedChemexpress LLC
|
FT113 [CAS 1630808-89-7]
|
|
Cancer-programmed cell death
|
|
|
HY-112066-1mg
|
MedChemexpress LLC
|
SHIN1 [CAS 2146095-85-2]
|
|
Cancer-programmed cell death
|
|
|
HY-112066-10mg
|
MedChemexpress LLC
|
SHIN1 [CAS 2146095-85-2]
|
|
Cancer-programmed cell death
|
|
|
HY-112066-100mg
|
MedChemexpress LLC
|
SHIN1 [CAS 2146095-85-2]
|
|
Cancer-programmed cell death
|
|
|
HY-112066-25mg
|
MedChemexpress LLC
|
SHIN1 [CAS 2146095-85-2]
|
|
Cancer-programmed cell death
|
|
|
HY-112066-5mg
|
MedChemexpress LLC
|
SHIN1 [CAS 2146095-85-2]
|
|
Cancer-programmed cell death
|
|
|
HY-112066-50mg
|
MedChemexpress LLC
|
SHIN1 [CAS 2146095-85-2]
|
|
Cancer-programmed cell death
|
|
|
HY-115510-10mg
|
MedChemexpress LLC
|
SPR inhibitor 3 [CAS 1292285-54-1]
|
|
COVID-19-immunoregulation
|
|
